Could psychedelics help patients in therapy? ...

Imagine if one day, your quiet neighborhood came alive with a steady hum… and it never went away? All throughout the United States, data centers are popping up next door and in your backyards. These buildings guzzle millions of water, cause noise pollution, and are raising homeow ...  Show more

Joel Bervell was one of the only Black students in his medical school program. After noticing how misconceptions about race were embedded in health care, he turned to social media to raise awareness about the harmful impact of biases in medicine. He unpacks the long history of ra ...  Show more

Send us Fan MailThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DM ...  Show more

In this episode Michelle interviews Dr. Steve Thayer, a clinical psychologist at Cedar Psychiatry, about his work using psychotherapy in conjunction with ketamine, a legal and safe psychedelic substance. Michelle shares her personal experience with Dr. Thayer when she participate ...  Show more

<span style= "font-size: 10.0pt; mso-bidi-font-family: Arial; mso-bidi-font-style: italic;"> What do the clinical trials of psilocybin and other psychedelics show in terms of efficacy and safety? How much of the benefit with psychedelic treatment is attributa ...

In this Huberman Lab Essentials episode, my guest is Dr. Matthew Johnson, PhD, a senior researcher for the Center of Excellence for Psilocybin Research and Treatment at Sheppard Pratt’s Institute for Advanced Diagnostics and Therapeutics. We explore the science and therapeutic po ...  Show more